Nadroparin Nearly Halves Risk Of Developing Blood Clots In Ambulatory Cancer Patients Receiving Chemotherapy
August 31, 2009 by Medical News
Filed under Health News
An article published Online First and in the October edition of The Lancet Oncology reports that the blood-thinning drug nadroparin halves the risk of developing blood clots in ambulatory cancer patients receiving chemotherapy. Consequently, it could become an important preventive treatment in these patients.
Read original article here
No TweetBacks yet. (Be the first to Tweet this post)
